Explore the Global Immunology-oncology ELISA Kits Market — Analysis of Key Trends, Regional Growth, Top Players, and a 10-Year Forecast from 2026 to 2036

Future Market Insights

Immunology-oncology ELISA Kits Market

Key Insight

Immunology-oncology ELISA kits sales will rise through 2036, driven by direct kits at 41% of the product segment in 2026. The market was valued at USD 10.80 billion in 2025 and is expected to be worth USD 15.94 billion by 2036, creating an incremental opportunity of USD 4.75 billion.

May 30, 2026

Anurag Sharma

290 Pages

Cite this Report

Immunology-oncology ELISA Kits Market

https://www.futuremarketinsights.com/reports/immunology-oncology-elisa-kits-market

License

Buy Now

Summary ToC Infographics Companies

Key Players

Abcam plc
BD Biosciences
Bio-Techne Corporation (R&D Systems)
Thermo Fisher Scientific Inc.

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Immunology-oncology ELISA Kits Market

Key Players

Similar Industry Reports